Kirk Tanner
Kirk Tanner" alt="Kirk Tanner" itemprop="image">
Company: National Brain Tumor Society
Job title: Chief Scientific Officer
Seminars:
Detailing the Opportunities for Epigenetic Drug Discovery & Development in CNS Tumors to Inform Pipeline Decision Making 1:45 pm
Glioblastoma is one of the first tumors where a single epigenetic modification, the methylation of the MGMT gene, was found to be of clinical relevance Cataloguing the additional alterations (IDH1/2 mutations and histone 3 variants) that either interfere with epigenetic modifier enzymes or alter alter global H3K27me3 levels Overviewing the landscape of opportunities for therapeutic…Read more
day: Day One